The actuarial survival analysis of the surgical and non-surgical therapy regimen for chronic thromboembolic pulmonary hypertension

  • Hui-Li Gan
  • Jian-Qun Zhang
  • Ping Bo
  • Qi-Wen Zhou
  • Sheng-Xun Wang


Aim To characterize the in-hospital mortality and the actuarial survival of surgical and non-surgical therapy regimen in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). Methods A retrospective cohort study was conducted in 504 patients with CTEPH, who were treated surgically (n = 360), or non-surgically (n = 144) in Anzhen Hospital from February 1989 to August 2007. The patients in surgical group received a standard pulmonary thromboendarterectomy (PTE), while those in non-surgical group were given thrombolytic therapy. The actuarial survival of the two groups was determined with the Kaplan–Meier survival curves. Univariate analysis and multivariate binary logistic regression and Cox proportional hazard analysis were used to identify the risk factors for the in-hospital and late deaths. Results The in-hospital mortality for the surgical group and non-surgical group were 4.44% and 3.50%, respectively. For the proximal type of CTEPH, the actuarial survival at 10 and 15 years of the surgical group and non-surgical group were 94.60 ± 2.38%, 90.96 ± 4.24% and 81.4 ± 7.14%, 56.43 ± 14.7%, respectively (χ2 = 12.33, P = 0.0004). For the distal type of CTEPH, the actuarial survival at 10 and 15 years of the surgical group and non-surgical group were 71.78 ± 4.66%, 29.57 ± 15.1% and 69.84 ± 7.78%, 32.59 ± 13.7%, respectively (χ2 = 0.03, P = 0.874). Conclusion The PTE procedure has statistically superiority over thrombolytic therapy for the proximal type of CTEPH in terms of actuarial survival; however, for the distal type of CTEPH, the PTE procedure provides no benefits with regard to actuarial survival.


Chronic thromboembolic pulmonary hypertension Pulmonary thromboendarterectomy 



Chronic thromboembolic pulmonary hypertension


Pulmonary thromboendarterectomy


Deep hypothermia circulatory arrest


Pulmonary vascular resistance


Computer tomography angiography


  1. 1.
    Condliffe R, Kiely DG, Gibbs JS et al (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177:1122–1127CrossRefPubMedGoogle Scholar
  2. 2.
    Van Beek EJ, Kuijer PM, Buller HR et al (1997) The clinical course of the patients with suspected pulmonary embolism. Arch Intern Med 157:2593–2598CrossRefPubMedGoogle Scholar
  3. 3.
    Jamieson SW, Kapelanski DP (2000) Pulmonary endarterectomy. Curr Probl Surg 26:167–252Google Scholar
  4. 4.
    Archibald CJ, Auger WR, Fedullo PF et al (1999) Long term outcome after pulmonary thromboendarterctomy. Am J Respir Crit Care Med 160:523–528PubMedGoogle Scholar
  5. 5.
    Corsico AG, Darmini AM, Cerveri I et al (2008) Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 178:419–424CrossRefPubMedGoogle Scholar
  6. 6.
    Yoshimi S, Tanabe N, Masuda M et al (2008) Survival and quality of life for patients with distal type chronic thromboembolic pulmonary hypertension. Circ J 72:958–965CrossRefPubMedGoogle Scholar
  7. 7.
    Suntharalingam J, Machado RD, Sharples LD et al (2007) Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension. Thorax 62:617–622CrossRefPubMedGoogle Scholar
  8. 8.
    Thistlethwaite PA, Lee SH, Du L, Wolf PL et al (2001) Human angiopoietin gene expression is a marker for severity ofpulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 122:65–73CrossRefPubMedGoogle Scholar
  9. 9.
    Pietra GG, Edward WD, Kay JM et al (1989) Histopathology of primary pulmonary hypertension. A qualitative andquantitative study of pulmonary blood vessels from 58 patients in the National heart, lung, and blood institute, primary pulmonary hypertension registry. Circulation 80:1198–1206PubMedGoogle Scholar
  10. 10.
    Carbrol S, Souza R, Jais X (2007) Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 26:357–362CrossRefGoogle Scholar
  11. 11.
    Nagaya N, Sasaki N, Ando M et al (2003) Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 123:338–343CrossRefPubMedGoogle Scholar
  12. 12.
    Bresser P, Fedullo PF, Auger WR et al (2004) Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 23:595–600CrossRefPubMedGoogle Scholar
  13. 13.
    Ulrich S, Speich R, Domenighetti G et al (2007) Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss Med Wkly 137:573–580PubMedGoogle Scholar
  14. 14.
    Bresser P, Pepke-Zaba J, Jais X et al (2006) Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc 3:594–600CrossRefPubMedGoogle Scholar
  15. 15.
    Suntharalingam J, Treacy CM, Doughty NJ et al (2008) Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 134:229–236CrossRefPubMedGoogle Scholar
  16. 16.
    Huges RJ, Jais X, Bonderman D et al (2006) The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J 28:138–143CrossRefGoogle Scholar
  17. 17.
    Romaszkiewicz R, Lewczuk J, Piszko P et al (2006) Results of one-year anticoagulation in patients with newly detected chronic thromboembolic pulmonary hypertension not treated with pulmonary endarterectomy. Kardiol Pol 64:1196–1202PubMedGoogle Scholar
  18. 18.
    Kim NHS (2006) Assessment of operability in chronic thromboembilic pulmonary hypertersion. Proc Am Thorac Soc 3:584–588CrossRefPubMedGoogle Scholar
  19. 19.
    Piszko P, Lewczuk J, Lenartowska L et al (2007) Pulmonary thromboembolism in 102 consecutive patients with chronic atrial fibrillation. Diagnostic value of echocardiography. Kardiol Pol 65:246–251PubMedGoogle Scholar
  20. 20.
    Raisinghani A, Ben-Yehuda O (2006) Echocardiography in chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 18:230–235CrossRefPubMedGoogle Scholar
  21. 21.
    Hardziyenka M, Reesink HJ et al (2007) A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Eur Heart J 28:842–849CrossRefPubMedGoogle Scholar
  22. 22.
    Naeije R, Huez S (2007) Reflections on wave reflections in chronic thromboembolic pulmonary hypertension. Eur Heart J 28:785–787CrossRefPubMedGoogle Scholar
  23. 23.
    Bonderman D, Skoro-Sajer N, Jakowitsch J et al (2007) Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 115:2153–2158CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Hui-Li Gan
    • 1
  • Jian-Qun Zhang
    • 1
  • Ping Bo
    • 1
  • Qi-Wen Zhou
    • 1
  • Sheng-Xun Wang
    • 1
  1. 1.Department of Cardiac Surgery, Beijing Anzhen HospitalCapital Medical University (BAZH–CMU), Beijing Institute of Heart, Lung and Vessel DiseaseBeijingChina

Personalised recommendations